1. Home
  2. OEC vs AARD Comparison

OEC vs AARD Comparison

Compare OEC & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$6.50

Market Cap

319.6M

Sector

Industrials

ML Signal

HOLD

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$3.77

Market Cap

281.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OEC
AARD
Founded
1862
2017
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
281.1M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
OEC
AARD
Price
$6.50
$3.77
Analyst Decision
Sell
Buy
Analyst Count
4
10
Target Price
$6.44
$19.63
AVG Volume (30 Days)
765.0K
487.6K
Earning Date
05-06-2026
03-23-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,806,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.06
$2,107.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$3.35
52 Week High
$12.84
$17.94

Technical Indicators

Market Signals
Indicator
OEC
AARD
Relative Strength Index (RSI) 64.02 22.87
Support Level $5.84 N/A
Resistance Level $6.58 $6.19
Average True Range (ATR) 0.35 0.39
MACD 0.21 0.15
Stochastic Oscillator 95.48 18.23

Price Performance

Historical Comparison
OEC
AARD

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: